COMBINATION THERAPY OF T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES CD3 ABD FOLATE RECEPTOR 1 (FOLR1) AND PD-1 AXIS BINDING ANTAGONISTS

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG

发明人:

KLEIN, Christian,KARANIKAS, Vaios,UMANA, Pablo,ZIPPELIUS, Alfred,THOMMEN, Daniela,SCHREINER, Jens

申请号：

SG11201704056X

公开号：

SG11201704056XA

申请日:

2015.11.16

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

The present invention generally relates to T cell activating bispecific antigen binding molecules, PD-1 axis binding antagonists, and in particular to combination therapies employing such T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists, and their use of these combination therapies for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/